Startseite Medizin The neuroprotective effect of magnesium sulfate in preterm fetal mice
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The neuroprotective effect of magnesium sulfate in preterm fetal mice

  • Geum Joon Cho , Hye-Ri Hong , Soon-Cheol Hong , Min-Jeong Oh EMAIL logo und Hai-Joong Kim
Veröffentlicht/Copyright: 11. Dezember 2014

Abstract

Objective: To investigate the use of magnesium sulfate (MgSO4) as a neuroprotective agent in a mouse model of inflammation-associated and noninflammation-associated preterm birth.

Methods: On embryonic day 15 of gestation, lipopolysaccharide (LPS) and mifepristone (RU486) were used, respectively, to create mouse models of inflammation and noninflammation-associated preterm birth. After intraperitoneal injection of LPS, RU486, or normal saline solution (NS), dams were randomized to intraperitoneal MgSO4 or NS injection. From the 6 treatment groups (NS+NS, LPS+NS, NS+MgSO4, LPS+MgSO4, RU486+NS and RU486+MgSO4), fetal brains were collected for Western blot analysis and neuronal cultures. Protein expression of S100B was assessed, and immunohistochemistry was performed to detect NeuN. The numbers of NeuN-labeled cells were counted using confocal laser scanning microscopy.

Results: The expression of S100B significantly differed among the groups and was decreased in the LPS+MgSO4 group compared to the LPS+NS group. The expression of S100B did not differ between the RU486+NS and RU486+MgSO4 groups. NeuN-labeled cells were increased in the LPS+MgSO4 group compared with the LPS+NS group. NeuN-labeled cells were decreased in the RU486+MgSO4 group compared with the RU486+NS group.

Conclusions: We observed that prenatal treatment with MgSO4 was associated with decreased expression of S100B and increased numbers of NeuN-labeled cells in an inflammation-associated preterm mouse model but not in a noninflammation-associated preterm mouse model. Our results suggest that prenatal treatment of MgSO4 reduces inflammation-associated brain injury in fetal mice.


Corresponding author: Min-Jeong Oh, Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, 80, Guro-dong, Guro-gu, Seoul 152-703, Republic of Korea, Tel.: +82-2-2626-3141, Fax: +82-2-838-1560, E-mail:

References

[1] Himpens E, Van den Broeck C, Oostra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol. 2008;50:334–40.Suche in Google Scholar

[2] Marlow N, Wolke D, Bracewell MA, Samara M, EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352: 9–19.Suche in Google Scholar

[3] Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol. 2000;183:717–25.Suche in Google Scholar

[4] Nelson KB, Grether JK. More on prenatal magnesium sulfate and risk of cerebral palsy. J Am Med Assoc. 1997;278:1493.Suche in Google Scholar

[5] Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200:595–609.Suche in Google Scholar

[6] Burd I, Breen K, Friedman A, Chai J, Elovitz MA. Magnesium sulfate reduces inflammation-associated brain injury in fetal mice. Am J Obstet Gynecol. 2010;202:292e1–9.Suche in Google Scholar

[7] Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.Suche in Google Scholar

[8] Back SA. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev. 2006;12:129–40.Suche in Google Scholar

[9] Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, Mawrin C, et al. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007;8:2.Suche in Google Scholar

[10] Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 1996;21:134–40.Suche in Google Scholar

[11] Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37:417–29.Suche in Google Scholar

[12] Gazzolo D, Vinesi P, Bartocci M, Geloso MC, Bonacci W, Serra G, et al. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci. 1999;170:32–5.Suche in Google Scholar

[13] Gazzolo D, Bruschettini M, Lituania M, Serra G, Bonacci W, Michetti F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem. 2001;47:1836–8.Suche in Google Scholar

[14] Gazzolo D, Marinoni E, Di IR, Bruschettini M, Kornacka M, Lituania M, et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med. 2003;157:1163–8.Suche in Google Scholar

[15] Nagdyman N, Komen W, Ko HK, Muller C, Obladen M. Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res. 2001;49:502–6.Suche in Google Scholar

[16] Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem. 2002;48:2097–104.Suche in Google Scholar

[17] Garnier Y, Frigiola A, Li Volti G, Florio P, Frulio R, Berger R, et al. Increased maternal/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod Sci. 2009;16:758–66.Suche in Google Scholar

[18] Park ES, Park CI, Choi KS, Choi IH, Shin JS. Over-expression of S100B protein in children with cerebral palsy or delayed development. Brain Dev. 2004;26:190–6.Suche in Google Scholar

[19] Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992;116: 201–11.Suche in Google Scholar

[20] Hassen GW, Tian D, Ding D, Bergold PJ. A new model of ischemic preconditioning using young adult hippocampal slice cultures. Brain Res Brain Res Protoc. 2004;13:135–43.Suche in Google Scholar

[21] Xu GP, Dave KR, Vivero R, Schmidt-Kastner R, Sick TJ, Pérez-Pinzón MA. Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res. 2002;952:153–8.Suche in Google Scholar

[22] Jongen-Relo AL, Feldon J. Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions. Physiol Behav. 2002;76:449–56.Suche in Google Scholar

[23] Burd I, Bentz AI, Chai J, Gonzalez J, Monnerie H, Le Roux PD, et al. Inflammation-induced preterm birth alters neuronal morphology in the mouse fetal brain. J Neurosci Res. 2010;88:1872–81.Suche in Google Scholar

[24] Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr. 1999;11:487–91.Suche in Google Scholar

[25] Hirtz DG, Nelson K. Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr. 1998;10:131–7.Suche in Google Scholar

[26] Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42:1–8.Suche in Google Scholar

[27] Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, et al. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 1997;177:406–11.Suche in Google Scholar

[28] Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sébire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology. 2001;56:1278–84.Suche in Google Scholar

[29] Dribben WH, Creeley CE, Wang HH, Smith DJ, Farber NB, Olney JW. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology. 2009;96:23–32.Suche in Google Scholar

[30] Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev. 2002:CD001060.Suche in Google Scholar

[31] Scudiero R, Khoshnood B, Pryde PG, Lee KS, Wall S, Mittendorf R. Perinatal death and tocolytic magnesium sulfate. Obstet Gynecol. 2000;96:178–82.Suche in Google Scholar

[32] Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895–905.Suche in Google Scholar

The authors stated that there are no conflicts of interest regarding the publication of this article.

Received: 2014-5-25
Accepted: 2014-11-10
Published Online: 2014-12-11
Published in Print: 2015-9-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Risk factors for preterm birth and new approaches to its early diagnosis
  4. Review
  5. Avoiding the prenatal programming effects of glucocorticoids: are there alternative treatments for the induction of antenatal lung maturation?
  6. Original articles – Obstetrics
  7. The association of first trimester bleeding with preterm delivery
  8. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test
  9. The neuroprotective effect of magnesium sulfate in preterm fetal mice
  10. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling
  11. The unborn smoker: association between smoking during pregnancy and adverse perinatal outcomes
  12. Association of group B streptococcus colonization with early term births
  13. Association of maternal whole blood fatty acid status during the prenatal period with term birth dimensions: a cross-sectional study
  14. Predicting onset of labor from echogenicity of the cervical gland area on vaginal ultrasonography at term
  15. Disparity in post-treatment maternal circulating magnesium sulfate levels between twin and singleton gestation: Is this the missing link between plurality and adverse outcome?
  16. Original articles – Fetus
  17. Cardiovascular profile score in 44 fetuses with cervicofacial tumors
  18. First trimester tricuspid regurgitation and fetal abnormalities
  19. Gastroschisis: incidence and prediction of growth restriction
  20. Original articles – Newborn
  21. Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis
  22. First- and fifth-minute Apgar scores of 0–3 and infant mortality: a population-based study in São Paulo State of Brazil
  23. Feeding the feeble: steps towards nourishing preterm infants
  24. Book review
  25. Hot topics in perinatal medicine
  26. Erratum
  27. Erratum to: Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial
  28. Congress Calendar
  29. Congress Calendar
Heruntergeladen am 31.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2014-0176/pdf
Button zum nach oben scrollen